Track the CAREDX INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was filed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN HANNA. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
CAREDX INC is a company specializing in diagnostic solutions for organ transplant patients. It focuses on developing non-invasive tests to monitor graft health.